Podium Finish: US FDA’s 61 Novel Approvals In 2024 Fall Short Of 2023 Peak But Exceed Average

 
• By Bridget Silverman
  
The 2024 novel approval total was a top three finish. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pink Sheet Perspectives

More from Regulatory Trackers